Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breas

[sassy]

http://news.prnewswire.com/DisplayReleaseContent.aspx?ACCT=104&STORY=/www/story/06-01-2009/0005035665&EDATE=